Kumamoto, Japan

Khaled Greish


Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2010-2012

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovative Contributions of Inventor Khaled Greish

Introduction

Khaled Greish, an accomplished inventor based in Kumamoto, Japan, has made significant strides in the field of pharmaceuticals through his innovative research and patent achievements. With a total of two patents, his work primarily focuses on novel polymeric pharmaceutical agents aimed at enhancing cancer treatment efficacy.

Latest Patents

Khaled Greish's latest patents include one titled "Polymeric pharmaceutical agent for treatment of cancer and method for production of the same," where he introduces a polymeric agent capable of incorporating a large amount of a drug while selectively accumulating at tumor sites. This invention utilizes a metalloporphyrin derivative, such as zinc protoporphyrin, combined with a styrene-maleic acid copolymer via non-covalent bonds to create a micelle complex. This innovative approach allows for a significant improvement in cancer treatment by enabling targeted drug delivery and minimizing renal excretion.

His second patent, "Antitumor agent and process for producing the same," describes a polymeric antitumor agent formed through mutual interaction between a styrene-maleic acid copolymer and low-molecule antitumor agents such as anthracyclins and alkaloids. This invention aims to improve the specificity of antitumor agents towards cancer cells while reducing adverse effects on normal tissues. The development process includes dissolving the copolymer and antitumor agents in aqueous solutions, followed by micelle complex formation through pH adjustments.

Career Highlights

Throughout his career, Khaled Greish has demonstrated an unwavering commitment to advancing medical science through his inventions. His innovative approaches to creating targeted drug delivery systems exemplify the potential of polymeric formulations in pharmaceutical applications.

Collaborations

Khaled has engaged in notable collaborations during his career, particularly with Hiroshi Maeda, a distinguished professional in the field. Together, they have worked on advancing the understanding and development of novel pharmaceutical agents that target cancer treatment.

Conclusion

Khaled Greish's contributions to the field of pharmaceutical innovation serve as a testament to his dedication as an inventor. Through his patented work, he continues to inspire advancements in cancer treatment, demonstrating the significant impact of innovative thinking in the medical field. The potential of his inventions marks an important step forward in improving patient outcomes and enhancing the effectiveness of cancer therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…